Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Nabiximols> ?p ?o. }
Showing items 1 to 62 of
62
with 100 items per page.
- Nabiximols abstract "Nabiximols (USAN, trade name Sativex) is a patented cannabinoid oromucosal mouth spray developed by the UK company GW Pharmaceuticals for multiple sclerosis (MS) patients, who can use it to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. Nabiximols is distinct from all other pharmaceutically produced cannabinoids currently available because it is a mixture of compounds derived from Cannabis plants, rather than a mono-molecular synthetic product. The drug is a pharmaceutical product standardised in composition, formulation, and dose, although it is still effectively a tincture of the cannabis plant. Its principal active cannabinoid components are the cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD). The product is formulated as an oromucosal spray which is administered by spraying into the mouth. Each spray delivers a near 1:1 ratio of CBD to THC, with a fixed dose of 2.7 mg THC and 2.5 mg CBD. Nabiximols is also being developed in Phase III trials as a potential treatment to alleviate pain due to cancer. It has also been researched in various models of peripheral and central neuropathic pain.In May 2003 GW Pharmaceuticals and Bayer entered into an exclusive marketing agreement for GW’s cannabis-based medicinal extract product, to be marketed under the brand name Sativex. "Bayer has obtained exclusive rights to market Sativex in the UK. In addition, Bayer has the option for a limited period of time to negotiate the marketing rights in other countries in European Union and selected other countries around the world."In April 2011, GW licensed to Novartis the rights to commercialise nabiximols in Asia (excluding China and Japan), Africa and the Middle East (excluding Israel).".
- Nabiximols atcPrefix "N02".
- Nabiximols atcSuffix "BG10".
- Nabiximols casNumber "56575-23-6".
- Nabiximols pubchem "44148067".
- Nabiximols thumbnail THC-skeletal.png?width=300.
- Nabiximols wikiPageExternalLink www.gwpharm.com.
- Nabiximols wikiPageID "2079522".
- Nabiximols wikiPageRevisionID "598714024".
- Nabiximols atcPrefix "N02".
- Nabiximols atcSuffix "BG10".
- Nabiximols casNumber "56575".
- Nabiximols class Cannabinoid.
- Nabiximols class "Cannabinoid".
- Nabiximols component "Cannabidiol".
- Nabiximols component "Tetrahydrocannabinol".
- Nabiximols hasPhotoCollection Nabiximols.
- Nabiximols image "Cannabidiol.png".
- Nabiximols legalAu "Schedule 8".
- Nabiximols legalStatus "Rx-only".
- Nabiximols pubchem "44148067".
- Nabiximols routesOfAdministration "Oromucosal spray".
- Nabiximols tradename "Sativex".
- Nabiximols type "combo".
- Nabiximols verifiedfields "changed".
- Nabiximols verifiedrevid "458774294".
- Nabiximols subject Category:Cannabinoids.
- Nabiximols subject Category:Combination_drugs.
- Nabiximols subject Category:Medicinal_use_of_cannabis.
- Nabiximols type Agent114778436.
- Nabiximols type CausalAgent100007347.
- Nabiximols type CombinationDrugs.
- Nabiximols type Drug103247620.
- Nabiximols type Matter100020827.
- Nabiximols type PhysicalEntity100001930.
- Nabiximols type Substance100020090.
- Nabiximols type Drug.
- Nabiximols type FunctionalSubstance.
- Nabiximols comment "Nabiximols (USAN, trade name Sativex) is a patented cannabinoid oromucosal mouth spray developed by the UK company GW Pharmaceuticals for multiple sclerosis (MS) patients, who can use it to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. Nabiximols is distinct from all other pharmaceutically produced cannabinoids currently available because it is a mixture of compounds derived from Cannabis plants, rather than a mono-molecular synthetic product.".
- Nabiximols label "Nabiximols".
- Nabiximols label "Nabiximols".
- Nabiximols label "Nabiximols".
- Nabiximols label "Sativex".
- Nabiximols label "Sativex".
- Nabiximols label "Sativex".
- Nabiximols label "Sativex".
- Nabiximols label "Набиксимолс".
- Nabiximols label "ナビキシモルス".
- Nabiximols sameAs Nabiximols.
- Nabiximols sameAs Sativex.
- Nabiximols sameAs Nabiximols.
- Nabiximols sameAs Sativex.
- Nabiximols sameAs ナビキシモルス.
- Nabiximols sameAs Sativex.
- Nabiximols sameAs Sativex.
- Nabiximols sameAs m.06kr0w.
- Nabiximols sameAs Q891968.
- Nabiximols sameAs Q891968.
- Nabiximols sameAs Nabiximols.
- Nabiximols wasDerivedFrom Nabiximols?oldid=598714024.
- Nabiximols depiction THC-skeletal.png.
- Nabiximols isPrimaryTopicOf Nabiximols.